Modifying Metabolic Syndrome and Cardiovascular Risk for Prostate Cancer Patients on ADT Using a Risk Factor Modification Program and Continuous Fitbit Monitoring

Abroad (travel likely)RecruitingPHASE2

Conditions

Biochemically Recurrent Prostate Carcinoma · Metastatic Prostate Adenocarcinoma · Stage IV Prostate Cancer AJCC v8 · Stage IVA Prostate Cancer AJCC v8 · Stage IVB Prostate Cancer AJCC v8

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

M D Anderson Cancer Center, Houston, Texas, United States
Contact: Study coordinator (Christopher J. Logothetis) · 713-792-2830
Contact: Principal Investigator (Christopher J. Logothetis)

Study leads

Christopher J Logothetis
Principal Investigator
M.D. Anderson Cancer Center

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Prospective Monitoring of Subjects With Biochemically Recurrent Prostate Cancer Using 18FDCFPyL

Prostate Cancer · Biochemically Recurrent

Abroad (travel likely)Recruiting

Bethesda, United States

Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging

Biochemically Recurrent Prostate Carcinoma · Metastatic Prostate Carcinoma · Prostate Adenocarcinoma

Abroad (travel likely)RecruitingPHASE3

Anchorage, United States · Anchorage, United States

PyL in Patients With High Risk and Biochemically Recurrent Prostate Cancer

Prostate Cancer

Abroad (travel likely)RecruitingPHASE2

Irvine, United States

68Ga-PSMA-11 Efficacy in Detecting BCR Prostate Cancer in Chinese Patients

Biochemical Recurrence of Malignant Neoplasm of Prostate · Prostate Cancer · BCR Prostate Carcinoma

Abroad (travel likely)RecruitingPHASE3

Beijing, China · Changsha, China